ArticleBMC cancer2025
Prognostic value of risk factors in cervical squamous cell carcinoma based on tumour infiltration depth.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate whether the prognostic significance of distinct risk factors differs according to tumour infiltration depth in cervical squamous cell carcinoma.
methodsWe performed a retrospective cohort study of 621 patients treated at our institution between June 2012 and March 2019. Postoperative histopathological evaluation classified patients into two groups: Group 1 (n = 321) demonstrated complete full-thickness infiltration (100%) of the cervical stromal wall, whereas Group 2 (n = 320) exhibited partial stromal infiltration (≤ 80%).
resultsMultivariate Cox regression survival analysis revealed that tumour volume(gTV) > 30.8 cm³, lymph node metastasis(gLNM), and vaginal invasion(gVI) were independent prognostic factors for 5-year survival in Group 1 (all p < 0.05), associated with 163%, 206%, and 80% increased 5-year mortality risk, respectively. In Group 2, lymph node metastasis(gLNM) persisted as the sole independent prognostic factor for 5-year survival (p = 0.03), representing a 290% higher 5-year mortality risk.
conclusionLymph node metastasis remains an independent prognostic factor irrespective of tumour infiltration depth. With increasing infiltration depth, the prognostic significance of tumour volume, vaginal invasion, vascular involvement and pathological grade becomes more pronounced. For patients with serosal infiltration, postoperative concurrent chemoradiotherapy should be considered for those exhibiting large tumour volume or vaginal invasion, even in the absence of other high-risk factors, to reduce local recurrence and distant metastasis while improving survival outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.